このエントリーをはてなブックマークに追加
ID 67649
Author
Ninomiya, Kiichiro Center for Comprehensive Genomic Medicine, Okayama University Hospital Kaken ID
Ennishi, Daisuke Center for Comprehensive Genomic Medicine, Okayama University Hospital
Okamoto, Kunio Department of Medical Oncology, Kagawa Prefectural Central Hospital
Ando, Midori Department of Pathology, Kagawa Prefectural Central Hospital,
Nakamura, Satoko Department of Pathology, Kagawa Prefectural Central Hospital
Tomida, Shuta Center for Comprehensive Genomic Medicine, Okayama University Hospital Kaken ID researchmap
Ayada, Yoshiyuki Department of Pathology, Okayama University Hospital
Makimoto, Go Center for Clinical Oncology, Okayama University Hospital
Ichihara, Eiki Center for Clinical Oncology, Okayama University Hospital Kaken ID publons
Okita, Natsuko Research Management Division, Clinical Research Support Office, National Cancer Center Hospital
Toyooka, Shinichi Center for Comprehensive Genomic Medicine, Okayama University Hospital ORCID Kaken ID publons researchmap
Maeda, Yoshinobu Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Tabata, Masahiro Center for Clinical Oncology, Okayama University Hospital Kaken ID researchmap
Note
This is an Accepted Manuscript of an article published by American Society of Clinical Oncology (ASCO).
This fulltext file will be available in Sep. 2025.
Published Date
2024-09-19
Publication Title
JCO Precision Oncology
Volume
volume8
Publisher
American Society of Clinical Oncology (ASCO)
Start Page
e2400228
ISSN
2473-4284
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2024 by American Society of Clinical Oncology.
File Version
author
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1200/po.24.00228
Citation
Kiichiro Ninomiya et al., Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report. JCO Precis Oncol 8, e2400228(2024). DOI:10.1200/PO.24.00228
Funder Name
Ministry of Health, Labor, and Welfare
Japan Agency for Medical Research and Development
Ono Pharmaceutical Co., Ltd
Otsuka Pharmaceutical Co., Ltd
助成番号
19EA1008
23EA1011
20ck0106622h0001